跳转至内容
Merck
CN

110M-1

CD10 (56C6) Mouse Monoclonal Antibody

登录 查看组织和合同定价。

选择尺寸

关于此项目

NACRES:
NA.41
UNSPSC Code:
12352203

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

mouse

conjugate

unconjugated

antibody form

culture supernatant

antibody product type

primary antibodies

clone

56C6, monoclonal

description

For In Vitro Diagnostic Use in Select Regions (See Chart)

form

buffered aqueous solution

species reactivity

human

packaging

vial of 0.1 mL concentrate (110M-14)
vial of 0.5 mL concentrate (110M-15)
bottle of 1.0 mL predilute (110M-17)
vial of 1.0 mL concentrate (110M-16)
bottle of 7.0 mL predilute (110M-18)

manufacturer/tradename

Cell Marque®

technique(s)

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:10-1:50

isotype

IgG1

control

kidney, tonsil

shipped in

wet ice

storage temp.

2-8°C

visualization

cytoplasmic, membranous

Quality Level

100
500

Gene Information

human ... MME(4311)

相关类别

Analysis Note


IVD
IVD
IVD
RUO

General description

CD10, common acute lymphoblastic leukemia antigen, is expressed by a subset of T follicularhelper cells. CD10 has a direct role in cell growth and apoptosis and has been implicated intumor cells proliferation.3 CD10 expression has been reported in a variety of tissues; includingrenal cell carcinoma, hepatocellular carcinoma, and follicular lymphoma.

Other Notes

CD10 Positive Control Slides, Product No. 110S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

Physical form

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

Preparation Note

Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.

Legal Information

Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品？  

试试我们的产品选型工具.

法规信息

监管及禁止进口产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000509701
0000509701
0000509664
0000509664
0000448463

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Ankur R Sangoi et al.
Advances in anatomic pathology, 17(6), 377-393 (2010-10-23)
The diagnosis of metastatic clear cell renal cell carcinoma may be difficult in some cases, particularly in the small image-guided biopsies that are becoming more common. As targeted therapies for renal cell carcinoma are now standard treatment, the recognition and
W G McCluggage et al.
Histopathology, 39(3), 273-278 (2001-09-05)
The CD10 antigen is expressed in acute lymphoblastic leukaemia and follicle centre cell lymphoma. A recent study investigating the expression of CD10 in a wide range of non-haematopoietic neoplasms found positive staining in a small number of endometrial stromal sarcomas
A D Attygalle et al.
Histopathology, 50(4), 498-508 (2007-04-24)
To identify distinguishing histological, immunophenotypic and molecular genetic features between angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma (PTL). Nodal T-cell lymphomas examined (n =137), included AITL (n = 89), PTL (n = 22), anaplastic large cell lymphoma (n =
Swerdlow S, et al. WHO classification of tumours of hematopoietic and lymphoid tissues. 4th edition. 2008. P. 220,233,255,265,309.
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue, 220-220 (2008)
Swerdlow S, et al. WHO classification of tumours of hematopoietic and lymphoid tissues. 4th edition. 2008. P. 220,233,255,265,309.
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue, 220-220 (2008)
查看所有相关文献

相关内容

诊断性免疫组化操作步骤

诊断性免疫组化是一系列用于识别组织异常、建立预后并提示治疗方式的技术。其基本原理是一种抗原-抗体结合反应，利用酶或荧光染料来标记抗体，呈现出组织或组织切片中特定抗原的位置和分布。

Diagnostic Immunohistochemistry Procedures

Diagnostic immunohistochemistry overview highlights its importance in cancer diagnosis and detecting infectious diseases in modern clinical pathology.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持